Autologous Non-Hematopoietic Peripheral Blood Stem Cells

DB15867InvestigationalCell transplant therapies

Autologous non-hematopoietic peripheral blood stem cells have been created into a formulation for use in a clinical trial (NCT04473170) by the Abu Dhabi Stem Cells Center. The cells have the... The cells have the characterizations of CD90+, CD133+, Oct-4+, CD45-, and CD71-.

Also known as: NHPBSC · UAECell19
Code names: Autologous Non-Hematopoietic Peripheral Blood Stem Cells

Resolves to

Targets

Q01860POU5F1P02786TFRCP08575PTPRCO43490PROM1P04216THY1

What you can answer from here — as of July 08, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Autologous Non-Hematopoietic Peripheral Blood Stem Cells, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account